321 related articles for article (PubMed ID: 24329130)
1. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.
Bennett RC; Brough C; Miller DA; O'Donnell KP; Keen JM; Hughey JR; Williams RO; McGinity JW
Drug Dev Ind Pharm; 2015 Mar; 41(3):382-97. PubMed ID: 24329130
[TBL] [Abstract][Full Text] [Related]
2. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
[TBL] [Abstract][Full Text] [Related]
3. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.
LaFountaine JS; Jermain SV; Prasad LK; Brough C; Miller DA; Lubda D; McGinity JW; Williams RO
Eur J Pharm Biopharm; 2016 Apr; 101():72-81. PubMed ID: 26861929
[TBL] [Abstract][Full Text] [Related]
4. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
5. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.
Hughey JR; DiNunzio JC; Bennett RC; Brough C; Miller DA; Ma H; Williams RO; McGinity JW
AAPS PharmSciTech; 2010 Jun; 11(2):760-74. PubMed ID: 20443089
[TBL] [Abstract][Full Text] [Related]
6. Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing.
Hughey JR; Keen JM; Brough C; Saeger S; McGinity JW
Int J Pharm; 2011 Oct; 419(1-2):222-30. PubMed ID: 21864663
[TBL] [Abstract][Full Text] [Related]
7. Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing.
Ellenberger DJ; Miller DA; Kucera SU; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1957-1970. PubMed ID: 29541940
[TBL] [Abstract][Full Text] [Related]
8. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
[TBL] [Abstract][Full Text] [Related]
9. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
[TBL] [Abstract][Full Text] [Related]
10. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
[TBL] [Abstract][Full Text] [Related]
11. Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol
Gala U; Miller D; Williams RO
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32295245
[TBL] [Abstract][Full Text] [Related]
12. Supersaturation, nucleation, and crystal growth during single- and biphasic dissolution of amorphous solid dispersions: polymer effects and implications for oral bioavailability enhancement of poorly water soluble drugs.
Sarode AL; Wang P; Obara S; Worthen DR
Eur J Pharm Biopharm; 2014 Apr; 86(3):351-60. PubMed ID: 24161655
[TBL] [Abstract][Full Text] [Related]
13. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
[TBL] [Abstract][Full Text] [Related]
14. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
15.
Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
[TBL] [Abstract][Full Text] [Related]
16. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
17. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
[TBL] [Abstract][Full Text] [Related]
18. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
19. Homogeneity of amorphous solid dispersions - an example with KinetiSol
Jermain SV; Miller D; Spangenberg A; Lu X; Moon C; Su Y; Williams RO
Drug Dev Ind Pharm; 2019 May; 45(5):724-735. PubMed ID: 30653376
[TBL] [Abstract][Full Text] [Related]
20. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
